1. Market Research
  2. > Healthcare Market Trends
  3. > Diagnostics

Medical Diagnostics Industry Overview: Latest Market Reports & Studies

  • Currently 3/5 Stars.
  • 1
  • 2
  • 3
  • 4
  • 5
41 votes

Global Diagnostics Industry

The diagnostics industry involves testing patients to detect disease. Diagnosis can be used in the case of patients already presenting symptoms of disease, to screen asymptomatic patients as a matter of routine, and to allow ongoing testing in patients with disease to establish prognosis or check progress of therapy. The section is part of the wider healthcare industry.

The market can be broadly divided into:

  1. In vitro diagnostics (IVD), which refers to testing samples of blood, tissue, for example electrocardiography; and
  2. Diagnostic imaging, such as x-rays, computerized axial tomography (CAT), mammograms and magnetic resonance imaging (MRI).

Leading Market Segment

The IVD market, estimated at $44 billion in 2010, is predicted to reach $52 billion by 2013 with a compound annual grown rate of approximately 5%, according to research from RNCOS. A particularly profitable growth sector within IVD, molecular diagnostics is predicted to reach $15 billion by 2014 at a compound annual growth rate of just under 20% reports Renub Research. Infectious diseases account for more than a fifth of this segment, followed by oncology testing. By 2014 blood testing and genetic screening together will account for over a quarter of the market, with the US representing $6 billion of the molecular diagnostics market by that time.

Blood grouping reagent Export

Diagnostics Industry Regional Market Share

The In Vitro Diagnostic market is dominated by the US and the EU, which combined comprise about three quarters of the global market. This is because developed countries are witnessing a proliferation of diet and lifestyle related diseases such as cancer, diabetes and cardiovascular disease, whereas developing countries are more concerned with the diagnosis of infection and infectious disease.

In the lead, the IVD market in the US is forecast to grow 5.4% annually, reaching $23 billion in 2013. According to Global Industry Analysts, the US molecular diagnostics market will be over $6.35 billion by 2015.

Following behind, the EU represents the second-largest regional market, with its infectious-disease testing market estimated to reach $1.02 billion in 2012. There is strong growth in oncology testing and pharmacogenomics, which are predicted to show a compound annual growth rate of 10.71% and 11.05%, respectively, between 2011 and 2015.

Top 3 Medical Diagnostics Players

Roche is the market leader in IVD, holding approximately 20% of total market share, followed by Abbott and Siemens, each holding more than 10%.

Roche’s 20% market share represents yearly sales of $44 billion, with key products such as CoaguChek and Accu-Chek fueling the company’s growth. Roche saw 20% growth in Asia-Pacific alone and a 5% rise in the US. Acquisitions, such as in diabetes care (Medingo Ltd) and tissue diagnostics (Biolmagene Inc), should see continued market growth for Roche going forward.

In business for over 120 years, Abbott's sales in 2010 reached over $35 billion, and it invested $3.7 billion in R&D. Its main area of expertise in diagnostics is immunodiagnostics. Abbott's immunoassay diagnostic systems, AxSYM, is used to test for cardiovascular disease, cancer, infectious diseases and thyroid conditions.

Read more »

Customer Support

Talk to Sam

+33 4 37 65 17 06

120 Reports
Company, Demand, M&A
660 Statistics
Market Size, Finance, Company Financials
430 Reports
Company Financials, Company, Supply
1300 Statistics
Market Size, Finance, Company Financials
18 Reports
Demand, Market Size, Company
260 Statistics
Market Size, Demand, Finance
10 Reports
Demand, Company Financials, Market Size
100 Statistics
Market Size, Finance, Company Financials
35 Reports
Demographic, Demand, Supply
170 Statistics
Demographic, Environment, Finance
17 Reports
Company Financials, Company, Market Size
150 Statistics
Finance, Company Financials, Market Size
19 Reports
Company Financials, Company, Supply
110 Statistics
Finance, Company Financials, Market Size
15 Reports
Company Financials, Demand, Company
65 Statistics
Environment, Demographic, Company
5 Reports
Company Financials, Market Size, Demand
51 Statistics
Finance, Company Financials, Company
8 Reports
Social Conditions, Demand, M&A
39 Statistics
Demographic, Market Size, Supply

About 6900 reports

Purchase Reports From Reputable Market Research Publishers
(From € 135 - € 49545)

Cellular Health Screening/Health Testing Market by Type, Multitest, Sample, Collection Site, and Region - Global Forecast to 2022

Cellular Health Screening/Health Testing Market: Global Forecast until 2022

  • € 8452
  • Industry report
  • July 2017
  • by MarketsandMarkets

“Cellular health screening market projected to grow at a CAGR of 10.0% from 2017 to 2022.”The global cellular health screening market is expected to reach USD 3.42 billion by 2022 from USD 2.12 billion ...

Cancer Biomarkers Market: Global Forecast until 2022 € 6384 October 2017

Specimen Validity Testing Market: Global Forecast until ... € 5045 May 2018

In Vitro Diagnostics/IVD Market: Forecast until 2023 € 5045 March 2018

Thyroid Function Test Market: Global Forecast until 202 ... € 5045 February 2018

RSV Diagnostics Market: Global Forecast until 2022 € 5045 February 2018

Contract Research Organization Services Market: Global ... € 5045 February 2018

Esoteric Testing Market: Global Forecast until 2023 € 5045 January 2018

Drug Screening Market: Global Forecast until 2022 € 5045 January 2018

Clinical Laboratory Services Market: Global Forecasts u ... € 5045 December 2017


ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on